Vol. 6 (04) pp. 413-423 DOI: 10.21474/IJAR01/6875

COMPREHENSIVE INSIGHT INTO MANAGEMENT OF OSMF.

and
  • Senior Lecturer, Department of Oral Medicine and Radiology, Mansarovar Dental College Hospital and Research Centre, Bhopal, MP, India.
  • Senior Lecturer, Department of Oral Medicine and Radiology, RKDF Dental College and Research Centre, Bhopal, MP, India.
21 Downloads 149 Views
Crossref

Download Full Paper (PDF)

Article Analytics

References

  1. Gupta J, Srinivasan SV, Jonathan DM. Effiacy of betamethasone, placental extract and hyaluronidase in the treatment of OSMF: a comparative study. e-journal of dentistry 2012; 2:132-5.
  2. Aara A, Satishkumar GP, Vani C, Venkatreddy M , Sreekanth K, Ibrahim M. Comparative study of intralesional dexamethasone, hyaluronidase & oral pentoxifylline in patients with oral submucous fibrosis. Glob J Med Res 2012; 12:169?73.
  3. Reddy V, Wanjari PV, Banda NR, Reddy P. Oral submucous fibrosis: correlation of clinical grading to various habit factors. Int J Dent Clin 2011; 3:21-4.
  4. Tilakaratne WM, Klinikowski MF, Saku T, Peters TJ, Warnakulasuriya S. Oral submucous fibrosis: review on aetiology and pathogenesis. OralOncol 2006; 42:561-8.
  5. Tadakamadla J, Kumar S, Mamatha GP. Non-invasive management of oral submucous fibrosis: a review. J Oral Health Res 2011; 2:1-7.
  6. Dagli RJ, Kumar S, Mathur A, Balasubrimanyam G, Duraiswamy P, Kulkarni S. Prevalence of leukoplakia, oral submucous fibrosis, papilloma and its relation with stress among green marbles mine labourers. Indian Med Oral Pathol Oral Cir Bucal 2008; 13:687-92.
  7. Reibel J. Tobacco and oral diseases. Med Princ Pract 2003; 12:22?32.
  8. Needleman IG, Binnie VI, Ainamo A, Carr AB, Fundak A, Koeber A et al. Improving the effectiveness of tobacco use cessation. Int Dental J. 2010; 60:50-9.?
  9. Bartold PM. Dentinal hypersensitivity: a review. Aust Dent J 2006; 51:212-18.
  10. Miglani S, Aggarwal V, Ahuja B. Dentin hypersensitivity: recent trends in management. J Conserv Dent 2010; 13:218-24.
  11. Mehrotra D, Pradhan R, Gupta S. Retrospective comparison of surgical treatment modalities in 100 patients with oral submucous fibrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009; 107:1-10.
  12. Sinha SN, Jain PK. Intraoral injection of hydrocortisone and placental extract in oral submucous fibrosis. Indian J Otolaryngology 1978; 30:103-5.
  13. Vijayavel T, Ponni V. Management for oral submucous fibrosis ? a comprehensive review. Indian J Multidiscip Dent 2013; 4:869-74.
  14. Stapleton JA, Watson L, Spirling LI, Smith R, Milbrandt A, Ratcliffe M et al. Varenicline in the routine treatment of tobacco dependence: a pre?post comparison with nicotine replacement therapy and an evaluation in those with mental illness Addic 2008; 146?54.
  15. Gupta D,?Sharma SC. Oral submucous fibrosis--a new treatment regimen. J Oral Maxillofac Surg1988; 46:830-3.
  16. Ali FM, Prasant MC, Patil A, Aher V, Tahsildar S, Deshpande R. Oral submucous fibrosis: medical management. Glob JPublic Health 2012; 1:12-19.
  17. Kakar PK, Puri RK, Venkatachalam VP. Oral submucous fibrosis- treatment with hyalase. J Laryngol Otol 1985; 99:57-9.
  18. Lin HJ,?Lin JC. Treatment of oral submucous fibrosis by collagenase: effects on oral opening and eating function. Oral Dis 2007; 13:407-13.
  19. Katharia SK, Singh SP, Kulshreshtha VK. The effects of placenta extract in management of oral submucous fibrosis. IndianJ Pharmacol 1992; 24:181-3.
  20. Das DA, Balan A, Sreelata KT. Comparative study of the efficacy of curcumin and turmeric oil as chemopreventive agents in oral submucous fibrosis: a clinical and histopathological evaluation. J Ind Aca Oral Med Radiolo 2010; 22:88-92.
  21. Gupta M, Mishra P, Shrivastava K, Singh N. Oral submucous fibrosis- current concepts of aetiology & its management J App. Dent. Med. Sci. 2015; 1:28-39.
  22. Karemore TV, Karemore VA. Etiopathogenesis and treatment strategies of oral submucous fibrosis. J Indian Aca Oral Med Radiol 2011; 23:598-602.
  23. Shevale V, Rinku KD, Vruturaj SV, Milind SD. Management of oral sub-mucous fibrosis : a review. Indian J Dent Sci 2012; 2:107-14.
  24. Rajendran R. Oral submucous fibrosis: etiology, pathogenesis, and future research BullWorld?Health?Organ 1994; 72:985-96.
  25. Rajendran R, Rani V, Shaikh S. Pentoxifylline therapy: a new adjunct in the treatment of oral submucous fibrosis. Indian J Dent Res 2006; 17:190-8.
  26. Tai YS, Liu BY, Wang JT, Sun A, Kwan HW, Chiang CP. Oral administration of milk from cows immunised with human intestinal bacteria leads to significant improvements of symptoms and signs in patients with oral sub mucous fibrosis. J Oral Pathol Med 2001; 30:618-25.
  27. Johar N, Chaurasia S, Phulambrikar T. Management of oral submucous fibrosis: a review. Int J Oral Health Dent. 2017; 3:154-7.
  28. Suma GN, Arora MP, Lakhanpal M. Stem cell therapy: a novel treatment approach for oral mucosal lesions. J Pharm Bioall Sci 2015; 7:2-8.
  29. Sankaranarayanan S, Kailasam S, Elangovan S, Ravi VR, Sarkar S. Autologous bone marrow concentrate (Mononuclear Stem Cell) therapy in the treatment of oral submucous fibrosis.?J Indian Acad Oral Med Radiol.?2013; 25:1?4.
  30. Lavina T, Anjana B, Vaishali K. Haemoglobin levels in patients with oral submucous fibrosis. J Ind Aca Oral Med Radiolo2007; 19:329- 33.
  31. Borle RM, Borle SR. Management of oral submucous fibrosis: a conservative approach. J Oral Maxillofac Surg 1991; 49:788?91.
  32. Balabaskaran K, Srinivasan A. Treatment options for oral submucous fibrosis. J Dent Med Sci 2013; 10:33-5.
  33. Maher R, Aga P, Johnson NW, Sankaranarayanan R, Warnakulasuriya S. Evaluation of multiple micronutrient supplementations in the management of oral submucous fibrosis in Karachi, Pakistan. Nutr Cancer 1997; 27:41-7.
  34. Shetty P, Shenai P, Chatra L, Rao PK. Efficacy of spirulina as an antioxidant adjuvant to corticosteroid injection in management of oral submucous fibrosis. Indian J Dent Res 2013; 24:347-50.
  35. Dayanarayana U, Doggalli N, Patil K, Shankar J. Non surgical approaches in treatment of OSF. J Dent Med Sci 2014;13:63-9.
  36. Kumar A, Bagewadi A, Keluskar V, Singh M. Efficacy of lycopene in the oral submucous fibrosis. OralSurg?Oral?Med?Oral?Pathol?Oral?Radiol Endod 2007; 103:207?13.
  37. Rao PK. Efficacy of alpha lipoic acid in adjunct with intralesional steroids and hyaluronidase in the management of oral submucous fibrosis. J Cancer Res Ther 2010; 6:508-10.
  38. Taneja L, Nagpal A, Vohra P, Arya V. Oral submucous fibrosis: an oral physician approach. J Innov Dent 2011; 1:1-5.

How to Cite This Article

Christopher Vinay Shinde and Sahil Kohli. (2018); COMPREHENSIVE INSIGHT INTO MANAGEMENT OF OSMF., Int. J. of Adv. Res., 6 (04), 413-423, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/6875

Corresponding Author

SAHIL KOHLI
RKDF DENTAL COLLEGE AND RESEARCH CENTER
Creative Commons Attribution 4.0 This work is licensed under a Creative Commons Attribution 4.0 International License.